---
id: antimalarial-treatment-falciparum_255
category: antimicrobials
tags: [antimalarials, malaria, falciparum, treatment, CDC-guidelines]
deck: Infectious Diseases
created: 2025-01-11
modified: 2025-01-11
---

## Treatment of Chloroquine-Resistant P. falciparum

**Q:** What are the CDC-recommended first-line treatments for uncomplicated chloroquine-resistant *P. falciparum* malaria in the United States?

**A:**

**Preferred (when available):**
- **Artemether-lumefantrine (Coartem)** - 6-dose regimen over 3 days

**Alternative Options:**
1. **Atovaquone-proguanil (Malarone)** - 4 tablets daily × 3 days
2. **Quinine sulfate + doxycycline/tetracycline**
   - Quinine: 3 days (7 days for SE Asia infections)
   - + Doxycycline 100 mg BID × 7 days
3. **Mefloquine** - Reserved (neuropsychiatric adverse effects)

**Resistance Considerations:**
- **Mefloquine**: Avoid for SE Asia infections (resistance)
- **Sulfadoxine-pyrimethamine**: NOT recommended (widespread resistance)
- **Don't use prophylaxis drug** for treatment unless no alternatives

**Key Principle:** If species unknown → treat as chloroquine-resistant *P. falciparum*

**Media:**

**Sources:** [CDC Malaria Treatment Guidelines 2024], [CDC Yellow Book 2024 Malaria Chapter], [CDC Treatment Tables June 2024]
